MedTrace Logo

Influence of the PEPA Membrane on the Undernutrition Syndrome Inflammation in Chronic Hemodialysis

NCT04185571 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 106

Last updated 2019-12-04

No results posted yet for this study

Summary

NutriPEPA2 is a randomized, single-blind, prospective, multicenter trial, in two parallel arms to confirm that the adsorbent PEPA membrane may decrease mortality related to inflammation and malnutrition encountered in HD or HDF-treated stage 5 renal failure compared to a non-adsorbent synthetic membrane.

Conditions

  • ESRD

Interventions

DEVICE

PEPA

Sponsors & Collaborators

  • Theradial

    lead INDUSTRY

Principal Investigators

  • BERNARD HORY, Doctor · Centre de Néphrologie, 4 ter rue de la Forêt, Avignon, FRANCE

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-12
Primary Completion
2021-04-30
Completion
2021-12-31

Countries

  • France
  • Monaco

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04185571 on ClinicalTrials.gov